Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

A hepatocyte growth factor receptor (Met)−insulin receptor hybrid governs hepatic glucose metabolism

Nature Medicine volume 17, pages 1577–1584 (2011)Cite this article

Subjects

Abstract

Met is the transmembrane tyrosine kinase cell surface receptor for hepatocyte growth factor (HGF) and is structurally related to the insulin receptor (INSR) tyrosine kinase. Here we report that the HGF-Met axis regulates metabolism by stimulating hepatic glucose uptake and suppressing hepatic glucose output. We show that Met is essential for an optimal hepatic insulin response by directly engaging INSR to form a Met-INSR hybrid complex, which culminates in a robust signal output. We also found that the HGF-Met system restores insulin responsiveness in a mouse model of insulin refractoriness. These results provide new insights into the molecular basis of hepatic insulin resistance and suggest that HGF may have therapeutic potential for type 2 diabetes in the clinical setting.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: HGF-Met stimulates hepatocyte glucose uptake through crosstalk with INSR.
Figure 2: Met interacts with and phosphorylates INSR.
Figure 3: INSR activation and IRS recruitment to Met requires functional Met kinase.
Figure 4: Loss of Met function in the liver impairs glucose homeostasis.
Figure 5: HGF administration to diabetic mice dampens endogenous glucose efflux into blood.
Figure 6: Administering HGF to mice alters key gluconeogenic mediators in the liver.

Similar content being viewed by others

References

  1. Zarnegar, R. & Michalopoulos, G.K. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell Biol. 129, 1177–1180 (1995).

    Article  CAS  PubMed  Google Scholar 

  2. Birchmeier, C., Birchmeier, W., Gherardi, E. & Vande Woude, G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915–925 (2003).

    Article  CAS  PubMed  Google Scholar 

  3. Borowiak, M. et al. Met provides essential signals for liver regeneration. Proc. Natl. Acad. Sci. USA 101, 10608–10613 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Corso, S., Comoglio, P.M. & Giordano, S. Cancer therapy: can the challenge be MET? Trends Mol. Med. 11, 284–292 (2005).

    Article  CAS  PubMed  Google Scholar 

  5. Huh, C.-G. et al. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc. Natl. Acad. Sci. USA 101, 4477–4482 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. De Meyts, P. Insulin and its receptor: structure, function and evolution. Bioessays 26, 1351–1362 (2004).

    Article  CAS  PubMed  Google Scholar 

  7. Lemmon, M.A. & Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 141, 1117–1134 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hanke, S. & Mann, M. The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2. Mol. Cell Proteomics 8, 519–534 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Johnston, A.M., Pirola, L. & Van Obberghen, E. Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling. FEBS Lett. 546, 32–36 (2003).

    Article  CAS  PubMed  Google Scholar 

  10. Myers, M.G. Jr. & White, M.F. Insulin signal transduction and the IRS proteins. Annu. Rev. Pharmacol. Toxicol. 36, 615–658 (1996).

    Article  CAS  PubMed  Google Scholar 

  11. Saltiel, A.R. & Kahn, C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799–806 (2001).

    Article  CAS  PubMed  Google Scholar 

  12. Gross, D.N., Wan, M. & Birnbaum, M.J. The role of FOXO in the regulation of metabolism. Curr. Diab. Rep. 9, 208–214 (2009).

    Article  CAS  PubMed  Google Scholar 

  13. Wang, X. et al. A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol. Cell 9, 411–421 (2002).

    Article  CAS  PubMed  Google Scholar 

  14. Song, E. et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9, 347–351 (2003).

    Article  CAS  PubMed  Google Scholar 

  15. Taniguchi, C.M., Ueki, K. & Kahn, R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J. Clin. Invest. 115, 718–727 (2005); erratum 115, 1388 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Surwit, R.S. et al. Alprazolam reduces stress hyperglycemia in ob/ob mice. Psychosom. Med. 48, 278–282 (1986).

    Article  CAS  PubMed  Google Scholar 

  17. Turner, S.M., Linfoot, P.A., Neese, R.A. & Hellerstein, M.K. Sources of plasma glucose and liver glycogen in fasted ob/ob mice. Acta Diabetol. 42, 187–193 (2005).

    Article  CAS  PubMed  Google Scholar 

  18. Appasamy, R. et al. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab. Invest. 68, 270–276 (1993).

    CAS  PubMed  Google Scholar 

  19. Liu, M.L., Mars, W.M., Zarnegar, R. & Michalopoulos, G.K. Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver. Am. J. Pathol. 144, 129–140 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Bertola, A. et al. Hepatocyte growth factor induces glucose uptake in 3T3–L1 adipocytes through A Gab1/phosphatidylinositol 3-kinase/Glut4 pathway. J. Biol. Chem. 282, 10325–10332 (2007).

    Article  CAS  PubMed  Google Scholar 

  21. Perdomo, G. et al. Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells. J. Biol. Chem. 283, 13700–13706 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. DeAngelis, T., Morrione, A. & Baserga, R. Mutual interaction and reciprocal down-regulation between c-met and insulin receptor substrate-1. J. Cell. Physiol. 224, 658–663 (2010).

    Article  CAS  PubMed  Google Scholar 

  23. Tomita, K. et al. Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. Gastroenterology 126, 873–885 (2004).

    Article  CAS  PubMed  Google Scholar 

  24. Jiang, J.G., Johnson, C. & Zarnegar, R. Peroxisome proliferator-activated receptor gamma-mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element. J. Biol. Chem. 276, 25049–25056 (2001).

    Article  CAS  PubMed  Google Scholar 

  25. Kosone, T. et al. HGF ameliorates a high-fat diet-induced fatty liver. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G204–G210 (2007).

    Article  CAS  PubMed  Google Scholar 

  26. Marsenic, O. Glucose control by the kidney: an emerging target in diabetes. Am. J. Kidney Dis. 53, 875–883 (2009).

    Article  CAS  PubMed  Google Scholar 

  27. Mellado-Gil, J. et al. Disruption of hepatocyte growth factor/c-Met signaling enhances pancreatic beta-cell death and accelerates the onset of diabetes. Diabetes 60, 525–536 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank G.K. Michalopoulos and S. Strom (University of Pittsburgh) for providing primary rodent and human hepatocyte cultures. We also thank A. Eaker and C. Johnson for their technical assistance. This study was supported by an R01 grant (R01NIAA001871301) awarded to R.Z. by the US National Institutes of Health.

Author information

Author notes

  1. Arlee Fafalios and Jihong Ma: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

    Arlee Fafalios, Jihong Ma, Xinping Tan, John Stoops, Jianhua Luo, Marie C DeFrances & Reza Zarnegar

  2. McGowan Institute of Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

    Marie C DeFrances & Reza Zarnegar

  3. University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA

    Marie C DeFrances & Reza Zarnegar

Authors
  1. Arlee Fafalios
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jihong Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xinping Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John Stoops
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jianhua Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marie C DeFrances
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Reza Zarnegar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

R.Z. developed the hypothesis, designed the experimental approaches and interpreted data. A.F. and J.M. performed experiments, collected data and performed analyses. M.C.D. helped with the histological studies and data interpretation. J.L. performed the gene array studies. J.S. and X.T. performed mouse injection experiments, mouse tissue harvesting, immunohistostaining and other technical assays.

Corresponding author

Correspondence to Reza Zarnegar.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–9, Supplementary Table 1 and Supplementary Methods (PDF 1309 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fafalios, A., Ma, J., Tan, X. et al. A hepatocyte growth factor receptor (Met)−insulin receptor hybrid governs hepatic glucose metabolism. Nat Med 17, 1577–1584 (2011). https://doi.org/10.1038/nm.2531

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2531

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing